Zymeworks Inc. (NASDAQ:ZYME) Q3 2022 Results Conference Call November 8, 2022 4:30 PM ET Company Participants Jack Spinks - Head of Investor Relations Neil Klompas - President & COO Kenneth Galbraith - Chair and CEO Neil Josephson - CMO Paul Moore - Chief Scientific Officer Conference Call Participants Stephen Willey - Stifel Charles Zhu - Guggenheim Securities Hosni Mubarak - Citi Gena Wang - Barclays James Shin - Wells Fargo Amy Li - Jefferies Operator Ladies and gentlemen, thank you for standing by. This ...

zymeworks Corporate Update and Third Quarter 2022 Financial Results Zymeworks Inc. NYSE: ZYME November 8, 2022 www.zymeworks.com 2 Forward-Looking Statements This presentation and the accompanying oral commentary include "forward-looking statements" or information within the meaning of applicable securities legislation, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements in this presentation and the a ...

zymeworks Zymeworks Corporate Presentation September 2022 NYSE: ZYME www.zymeworks.com 2 Legal Disclaimer This presentation includes "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and "forward-looking information" within the meaning of Canadian securities laws, or collectively, forward looking statements. Forward-looking statements include statements that may relate to our plans, objectives, goals, strategies, future events, future revenue or per ...

zymeworks Zymeworks Corporate Presentation September 2022 NYSE: ZYME www.zymeworks.com 2 Legal Disclaimer This presentation includes "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and "forward-looking information" within the meaning of Canadian securities laws, or collectively, forward looking statements. Forward-looking statements include statements that may relate to our plans, objectives, goals, strategies, future events, future revenue or per ...

Zymeworks Inc. (NASDAQ:ZYME) Q2 2022 Results Conference Call August 4, 2022 4:30 PM ET Company Participants Jack Spinks - Associate Director of Investor Relations Ken Galbraith - Chair and CEO Dr. Neil Josephson - CMO Conference Call Participants Yigal Nochomovitz - Citi Nick Abbott - Wells Fargo Charles Zhu - Guggenheim Securities Stephen Willey - Stifel Amy Li - Jefferies Operator Thank you for standing. This is the conference operator. Welcome to Zymeworks Second Quarter 2022 Results Conference Call and ...

zymeworks Jefferies Healthcare Conference Ken Galbraith, Chair & CEO NYSE: ZYME June 8, 2022 www.zymeworks.com 2 Forward-Looking Statements This presentation includes "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and "forward-looking information" within the meaning of Canadian securities laws, or collectively, forward looking statements. Forward-looking statements include statements that may relate to our plans, objectives, goals, strategies, fu ...

Making Therapies that Make a Difference CORPORATE OVERVIEW NYSE: ZYME www.zymeworks.com Legal Disclaimer This presentation includes "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and "forward-looking information" within the meaning of Canadian securities laws, or collectively, forward looking statements. Forward-looking statements include statements that may relate to our plans, objectives, goals, strategies, future events, future revenue or perf ...

Zymeworks Inc. (NASDAQ:ZYME) Q1 2022 Results Conference Call May 4, 2022 4:30 PM ET Company Participants Jack Spinks - Associate Director of Investor Relations Neil Klompas - Chief Operating Officer Kenneth Galbraith - Chair and CEO Chris Astle - SVP and CFO Neil Josephson - CMO Conference Call Participants Stephen Willey - Stifel Charles Zhu - Guggenheim Securities Josh Schimmer - Evercore Nick Abbott - Well Fargo Akash Tewari - Jefferies David Martin - Bloom Burton Operator Good day and thank you for stan ...

zymeworks Barclays Global Healthcare Conference Neil Klompas NYSE: ZYME Chief Operating Officer www.zymeworks.com 2 Legal Disclaimer This presentation includes "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and "forward-looking information" within the meaning of Canadian securities laws, or collectively, forward looking statements. Forward-looking statements include statements that may relate to our plans, objectives, goals, strategies, future ev ...

zymeworks Corporate Update and Year-End 2021 Financial Results Zymeworks Inc NYSE: ZYME February 24, 2022www.zymeworks.com 2 Legal Disclaimer This presentation Securities Litigation Reform Act of 1995 and "forward-looking information" within the meaning of Canadian securities laws, or collectively, forward looking statements. Forward-looking statements include statements that may relate to implementation of our strategic priorities; clinical development of our product candidates, related clinical trials, an ...